Company
EpiFrontier Therapeutics, Inc.
Breakthrough Epigenetic Therapeutics for Sickle Cell Disease.
Also known as EpiFrontier Therapeutics
- Business model
- B2B
- Legal name
- EpiFrontier Therapeutics, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
EpiFrontier is a biotechnology company developing oral therapies for hemoglobinopathies. Our goal is to deliver treatments that are accessible to patients worldwide, including those in regions with limited healthcare resources.
Products
- Web
- EPF-001
Loading relationship preview